Baker Bros. Advisors LP
- SEC CIK
- 0001263508
- Latest filing
- Aug 14, 2026
ACRV holding history
Acrivon Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACRV overviewAll 13F holders of ACRVFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −22,809−100.0% | Sold out | Holders |
| Q4 2025 | 22,809 | $55.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 22,809 | $41.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 22,809 | $27.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 22,809 | $46.3K | <0.1% | −30,076−56.9% | Reduced | Holders |
| Q4 2024 | 52,885 | $318.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 52,885 | $370.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 52,885 | $306.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 52,885 | $378.1K | <0.1% | +52,885 | New | Holders |